Authors:
Nzila, AM
Mberu, EK
Sulo, J
Dayo, H
Winstanley, PA
Sibley, CH
Watkins, WM
Citation: Am. Nzila et al., Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase anddihydropteroate synthase of Kenyan parasites, ANTIM AG CH, 44(4), 2000, pp. 991-996
Citation: Am. Nzila et al., Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan (vol 181, pg 2023, 2000), J INFEC DIS, 182(3), 2000, pp. 1011-1011
Authors:
Nzila, AM
Nduati, E
Mberu, EK
Sibley, CH
Monks, SA
Winstanley, PA
Watkins, WM
Citation: Am. Nzila et al., Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum, J INFEC DIS, 181(6), 2000, pp. 2023-2028
Authors:
Mberu, EK
Mosobo, MK
Nzila, AM
Kokwaro, GO
Sibley, CH
Watkins, WM
Citation: Ek. Mberu et al., The changing in vitro susceptibility pattern to pyrimetharnine/sulfadoxinein Plasmodium falciparum field isolates from Kilifi, Kenya, AM J TROP M, 62(3), 2000, pp. 396-401
Authors:
Kinyanjui, SM
Mberu, EK
Winstanley, PA
Jacobus, DP
Watkins, WM
Citation: Sm. Kinyanjui et al., The antimalarial triazine WR99210 and the prodrug PS-15: Folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate modeof action of the prodrug, AM J TROP M, 60(6), 1999, pp. 943-947